Intravascular Ultrasound for Hepatocellular Carcinoma Staging
Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study
1 other identifier
observational
N/A
1 country
1
Brief Summary
To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm. Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential. As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 15, 2007
CompletedFirst Posted
Study publicly available on registry
May 17, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedMay 17, 2007
May 1, 2007
May 15, 2007
May 16, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- hepatocellular carcinoma nodules
- patient on liver transplantation waiting list
- written informed consent
You may not qualify if:
- thrombosis of hepatic veins or vena cava
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Geneva
Geneva, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Antoine Hadengue, Prof.
University Hospital, Geneva
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 15, 2007
First Posted
May 17, 2007
Study Start
May 1, 2007
Study Completion
September 1, 2007
Last Updated
May 17, 2007
Record last verified: 2007-05